Cargando…

A Drosophila Model for EGFR-Ras and PI3K-Dependent Human Glioma

Gliomas, the most common malignant tumors of the nervous system, frequently harbor mutations that activate the epidermal growth factor receptor (EGFR) and phosphatidylinositol-3 kinase (PI3K) signaling pathways. To investigate the genetic basis of this disease, we developed a glioma model in Drosoph...

Descripción completa

Detalles Bibliográficos
Autores principales:	Read, Renee D., Cavenee, Webster K., Furnari, Frank B., Thomas, John B.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2636203/ https://www.ncbi.nlm.nih.gov/pubmed/19214224 http://dx.doi.org/10.1371/journal.pgen.1000374

Ejemplares similares

Therapeutic resistance in cancer: microRNA regulation of EGFR signaling networks
por: Gomez, German G., et al.
Publicado: (2013)

Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma
por: Li, Ming, et al.
Publicado: (2011)

A Kinome-Wide RNAi Screen in Drosophila Glia Reveals That the RIO Kinases Mediate Cell Proliferation and Survival through TORC2-Akt Signaling in Glioblastoma
por: Read, Renee D., et al.
Publicado: (2013)

Therapeutic targeting of epidermal growth factor receptor in human cancer: successes and limitations
por: Wykosky, Jill, et al.
Publicado: (2011)

SL2 ADVANCES IN MOLECULAR BIOLOGY AND GENETICS IN GLIOMA RESEARCH AND THERAPY
por: Cavenee, Webster K
Publicado: (2019)

Current Approaches in NSCLC Targeting K-RAS and EGFR
por: Aran, Veronica, et al.
Publicado: (2019)

Syringin exerts anti-breast cancer effects through PI3K-AKT and EGFR-RAS-RAF pathways
por: Wang, Fei, et al.
Publicado: (2022)

Src Cooperates with Oncogenic Ras in Tumourigenesis via the JNK and PI3K Pathways in Drosophila epithelial Tissue
por: Poon, Carole L.C., et al.
Publicado: (2018)

Neutralizing the EGF receptor in glioblastoma cells stimulates cell migration by activating uPAR-initiated cell-signaling
por: Hu, Jingjing, et al.
Publicado: (2014)

The metabolomic landscape plays a critical role in glioma oncogenesis
por: Masui, Kenta, et al.
Publicado: (2022)

Alterations in the RTK/Ras/PI3K/AKT pathway serve as potential biomarkers for immunotherapy outcome of diffuse gliomas
por: Han, Song, et al.
Publicado: (2021)

Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy
por: Nitta, Masayuki, et al.
Publicado: (2010)

A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors
por: Loboda, Andrey, et al.
Publicado: (2010)

PRG3 induces Ras-dependent oncogenic cooperation in gliomas
por: Fan, Zheng, et al.
Publicado: (2016)

Correction: Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy
por: Nitta, Masayuki, et al.
Publicado: (2011)

Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines
por: Vitiello, Pietro Paolo, et al.
Publicado: (2019)

Does Ras Activate Raf and PI3K Allosterically?
por: Nussinov, Ruth, et al.
Publicado: (2019)

The Importance of Being PI3K in the RAS Signaling Network
por: Cuesta, Cristina, et al.
Publicado: (2021)

Differential Regulation of the EGFR/PI3K/AKT/PTEN Pathway between Low- and High-Grade Gliomas
por: Erira, Alveiro, et al.
Publicado: (2021)

PI3K-dependent cross-talk interactions converge with Ras as quantifiable inputs integrated by Erk
por: Wang, Chun-Chao, et al.
Publicado: (2009)

PI3K-dependent cross-talk interactions converge with Ras as quantifiable inputs integrated by Erk
por: Wang, Chun-Chao, et al.
Publicado: (2011)

Dynamic Control of Cell Cycle and Growth Coupling by Ecdysone, EGFR, and PI3K Signaling in Drosophila Histoblasts
por: Ninov, Nikolay, et al.
Publicado: (2009)

When less is more: Gaining power through gene rearrangement of amplified EGFR
por: Koga, Tomoyuki, et al.
Publicado: (2019)

Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibition
por: Shen, Ying, et al.
Publicado: (2015)

K-ras/PI3K-Akt Signaling Is Essential for Zebrafish Hematopoiesis and Angiogenesis
por: Liu, Lihui, et al.
Publicado: (2008)

Mutant K-Ras in Pancreatic Cancer: An Insight on the Role of Wild-Type N-Ras and K-Ras-Dependent Cell Cycle Regulation
por: Ferguson, Robert, et al.
Publicado: (2023)

EGFR/Ras Signaling Controls Drosophila Intestinal Stem Cell Proliferation via Capicua-Regulated Genes
por: Jin, Yinhua, et al.
Publicado: (2015)

EGFR and K-Ras mutations in women with lung adenocarcinoma: implications for treatment strategy definition
por: Rotella, Virginia, et al.
Publicado: (2014)

Clonorchis sinensis Granulin Promotes Malignant Transformation of Hepatocyte Through EGFR-Mediated RAS/MAPK/ERK and PI3K/Akt Signaling Pathways
por: Wang, Caiqin, et al.
Publicado: (2021)

Precision cancer therapy is impacted by oncogene-dependent epigenome remodeling
por: Liu, Feng, et al.
Publicado: (2017)

Disruption of the Interaction of RAS with PI 3-Kinase Induces Regression of EGFR-Mutant-Driven Lung Cancer
por: Murillo, Miguel M., et al.
Publicado: (2018)

Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma
por: Li, Jie, et al.
Publicado: (2014)

Roles of the PI-3K and MEK pathways in Ras-mediated chemoresistance in breast cancer cells
por: Jin, W, et al.
Publicado: (2003)

Sequential Ras/MAPK and PI3K/AKT/mTOR pathways recruitment drives basal extrusion in the prostate-like gland of Drosophila
por: Rambur, Amandine, et al.
Publicado: (2020)

Effects of RAF inhibitors on PI3K/AKT signalling depend on mutational status of the RAS/RAF signalling axis
por: Fritsche-Guenther, Raphaela, et al.
Publicado: (2016)

EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?
por: Paliga, A, et al.
Publicado: (2012)

Lysines K117 and K147 play conserved roles in Ras activation from Drosophila to mammals
por: Singh, Jiya, et al.
Publicado: (2023)

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC
por: Kalikaki, A, et al.
Publicado: (2008)

Targeting EGFR and PI3K pathways in ovarian cancer
por: Glaysher, S, et al.
Publicado: (2013)

Phosphorylated EGFR Dimers Are Not Sufficient to Activate Ras
por: Liang, Samantha I., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_aq8il15i2gjkvvvhs4nhaaf056